Omada Health is trading at $15.77, down 15.86% on November 6, 2026, with no specific catalyst identified for the decline. - On November 5, Q3 revenue rose 34% to $91 million, and the company raised its full-year revenue and adjusted EBITDA outlook; those results do not explain the selloff. - Healthcare stocks are down 1.48%, a modest decline relative to Omada Health’s move, and no reliable report directly links the sector to the drop.